NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide.
about
Granulocyte colony-stimulating factor activating HIF-1alpha acts synergistically with erythropoietin to promote tissue plasticitySerum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype.Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target EngagementRedox control of microglial function: molecular mechanisms and functional significanceThe pathobiology of vascular dementiaCross talk between mitochondria and NADPH oxidasesCoenzyme Q10 protects human endothelial cells from β-amyloid uptake and oxidative stress-induced injuryNox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein.Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease.Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.NADPH oxidase as a therapeutic target in Alzheimer's disease.Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain.Soluble amyloid-beta, effect on cerebral arteriolar regulation and vascular cellsRole of vascular risk factors and vascular dysfunction in Alzheimer's disease.Catalytic antioxidants and neurodegenerationIbuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's diseaseTransgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's diseaseBrain and circulating levels of Aβ1-40 differentially contribute to vasomotor dysfunction in the mouse brain.Microglial P2X₇ receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease.Resveratrol treatment rescues neurovascular coupling in aged mice: role of improved cerebromicrovascular endothelial function and downregulation of NADPH oxidase.Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice.The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction.Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy.Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer's diseaseProtecting against vascular disease in brainStress, exercise, and Alzheimer's disease: a neurovascular pathway.Neurovascular function in Alzheimer's disease patients and experimental models.The role of oxidative stress and NADPH oxidase in cerebrovascular disease.The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's diseaseRole of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's diseaseNox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2PACAP38/PAC1 signaling induces bone marrow-derived cells homing to ischemic brain.Astrocyte regulation of blood flow in the brainRegional Heterogeneity of Cerebral Microvessels and Brain Susceptibility to Oxidative StressNOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.Mechanism of oxidative stress in neurodegeneration.Statins Inhibit Fibrillary β-Amyloid Induced Inflammation in a Model of the Human Blood Brain Barrier.Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke.Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease.
P2860
Q21136403-7560B436-D8DF-4D9A-94FA-A745B3AE354EQ24292785-C0F13FCE-FA64-4B7E-BF5F-8C9AE4171CFAQ26751153-E3A20DB0-8833-4AF7-AF66-023F22BE4D0EQ26861119-9EA1DCA3-8A9A-49F2-BF94-4313601D7915Q27000279-FE95AD71-B0E5-4A11-9EDA-7D310EEFCE9BQ27006033-0FD08653-1849-4DC8-BA4D-FDF870ED7A0AQ28391403-D5058D5D-26FD-46B0-BB9D-A77CD9E1D3C6Q28543468-0CAB17D8-64B1-4C8D-B1A5-23EB24F09F57Q30481236-AC88A9CE-A2FB-46D0-88BF-ECD622833E67Q30499926-7A7C5E7B-0BEA-4BA8-A6CD-B6A0BBCD2549Q30623665-0911FD38-CD46-4CC2-B374-369728E27D5BQ30855129-356DAAB7-593C-42E7-A8F4-A6D6E33EFABEQ33281864-FC2AABB4-F15A-4782-95CA-16AFABC89E3BQ33863420-FB8CA126-0D91-42F2-BE32-77EE11A9422EQ34055011-52D8701E-96D4-4B3B-A601-FB90F3738A81Q34104938-D1088CC2-6FE7-4821-B0D7-9FA4DEDD511AQ34306241-2231BD88-0A9B-4A30-88D6-F7055376B85EQ34358146-915933F4-2FB7-4A60-882C-435A8C94B144Q34498055-4C47831B-988E-4A59-A2F2-084D7B026587Q34587134-B385DA5E-0471-4044-BEE8-3F833F95653CQ34658269-E372CC77-E8C0-461D-9BFF-A456C6D886C1Q34704978-567B73C4-F604-435F-9C30-347A6269B2A8Q34820753-C56BD39D-83F3-4D83-9EE0-09630AD7F9CFQ34828890-405E7403-9862-48F1-97F2-BB5B769F8E4BQ34914124-B150251E-2478-46D1-AA5D-B23C113FCB99Q34979773-64543380-DFE1-41BD-9650-99C218F9F1B4Q34981226-5FC21EF8-6117-44F6-A07B-97F2FF54CFFCQ35088223-98382051-9EC9-497B-BA3D-454BE72115F3Q35118380-1A8D1E41-B61A-4585-99B7-A26D1F161E09Q35132234-FD3C3024-970C-48B7-9948-BB3763B88DC2Q35141182-1CCC3BCA-0B09-4C0C-85B5-A5C420B1F958Q35486123-9D8ACA19-5C7A-4404-9ADE-B03E212378D6Q35535637-E7599257-43DB-4788-98CE-5510D2646F6AQ35663954-93C7FE54-2BB3-4FD4-8496-B395AFD51CB1Q35858581-53CB29B6-54EB-412A-B278-4656BAAE0970Q35985407-6A375709-CCCA-4689-9F9A-C3CF0681A9D9Q35996874-7BC3C51A-AF5A-4DC5-9CA5-EBF31EDDC50DQ36054103-D8B6D94C-D55A-4B80-98D0-763503CBA6DCQ36249538-4E321A51-E34A-40E1-B84C-3754D55CA870Q36343094-F7F583B7-0BA9-4D3D-BD2B-D9A465C17FE1
P2860
NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
NADPH-oxidase-derived reactive ...... d by the amyloid beta peptide.
@ast
NADPH-oxidase-derived reactive ...... d by the amyloid beta peptide.
@en
type
label
NADPH-oxidase-derived reactive ...... d by the amyloid beta peptide.
@ast
NADPH-oxidase-derived reactive ...... d by the amyloid beta peptide.
@en
prefLabel
NADPH-oxidase-derived reactive ...... d by the amyloid beta peptide.
@ast
NADPH-oxidase-derived reactive ...... d by the amyloid beta peptide.
@en
P2093
P1476
NADPH-oxidase-derived reactive ...... ed by the amyloid beta peptide
@en
P2093
George A Carlson
Josef Anrather
Kelly Frys
Rose Pitstick
Steven Younkin
P304
P356
10.1523/JNEUROSCI.5207-04.2005
P407
P577
2005-02-01T00:00:00Z